SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

MANFRINATO, Maria Cristina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.055
AS - Asia 2.706
EU - Europa 1.790
SA - Sud America 433
AF - Africa 55
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 5
Totale 10.052
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.960
SG - Singapore 1.044
CN - Cina 866
BR - Brasile 362
UA - Ucraina 313
IT - Italia 310
DE - Germania 304
HK - Hong Kong 255
GB - Regno Unito 210
VN - Vietnam 170
TR - Turchia 156
FI - Finlandia 132
PL - Polonia 117
RU - Federazione Russa 96
SE - Svezia 82
CA - Canada 48
ID - Indonesia 40
MX - Messico 39
EE - Estonia 36
FR - Francia 33
AR - Argentina 30
IN - India 28
NL - Olanda 28
BE - Belgio 26
JP - Giappone 23
CZ - Repubblica Ceca 21
IQ - Iraq 21
ZA - Sudafrica 21
BD - Bangladesh 20
ES - Italia 17
LT - Lituania 14
EC - Ecuador 12
CO - Colombia 11
IR - Iran 11
IE - Irlanda 8
MA - Marocco 8
MY - Malesia 8
SA - Arabia Saudita 8
AT - Austria 7
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
EG - Egitto 6
KR - Corea 6
PY - Paraguay 6
RO - Romania 6
SD - Sudan 6
UY - Uruguay 6
BG - Bulgaria 5
KE - Kenya 5
PT - Portogallo 5
TW - Taiwan 5
A2 - ???statistics.table.value.countryCode.A2??? 4
EU - Europa 4
PK - Pakistan 4
AU - Australia 3
CL - Cile 3
JM - Giamaica 3
KW - Kuwait 3
MD - Moldavia 3
NP - Nepal 3
OM - Oman 3
PS - Palestinian Territory 3
TN - Tunisia 3
AF - Afghanistan, Repubblica islamica di 2
AL - Albania 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
ET - Etiopia 2
GE - Georgia 2
GR - Grecia 2
IL - Israele 2
KZ - Kazakistan 2
LV - Lettonia 2
NZ - Nuova Zelanda 2
PA - Panama 2
RS - Serbia 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
VE - Venezuela 2
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
CI - Costa d'Avorio 1
GN - Guinea 1
HR - Croazia 1
HU - Ungheria 1
JO - Giordania 1
KH - Cambogia 1
LB - Libano 1
MK - Macedonia 1
PE - Perù 1
PH - Filippine 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TL - Timor Orientale 1
TT - Trinidad e Tobago 1
Totale 10.052
Salva come PNG Salva come JPEG
Città #
Singapore 610
Woodbridge 521
Ashburn 461
Fairfield 340
Jacksonville 331
Chandler 324
Beijing 315
Houston 312
Santa Clara 285
Ann Arbor 281
Hong Kong 251
Wilmington 139
Dallas 130
Ferrara 129
Cambridge 113
Seattle 111
Nanjing 110
Warsaw 103
Izmir 100
Munich 87
Los Angeles 83
Princeton 81
Boardman 66
Ho Chi Minh City 59
Dearborn 57
New York 47
Milan 45
Nanchang 37
Shanghai 37
Shenyang 35
Hanoi 34
San Diego 33
São Paulo 33
Turku 33
Helsinki 32
Tianjin 30
Changsha 29
London 28
Brussels 26
Mexico City 25
Bologna 23
Buffalo 22
Tokyo 21
Jakarta 20
Poplar 20
Bremen 19
Brno 18
Brooklyn 18
Hefei 17
Jiaxing 17
Montreal 17
Boston 16
Chicago 16
Denver 16
Hebei 16
Moscow 15
Ningbo 15
Orange 15
Addison 14
Chennai 14
Orem 14
Stockholm 14
Frankfurt am Main 13
Jinan 13
Norwalk 13
Phoenix 13
San Francisco 12
San Mateo 12
Redwood City 11
Toronto 11
Atlanta 10
Augusta 10
Mountain View 10
Auburn Hills 9
Curitiba 9
Dong Ket 9
Kraków 9
Philadelphia 9
The Dalles 9
Washington 9
Baghdad 8
Dublin 8
Johannesburg 8
Manchester 8
Des Moines 7
Falkenstein 7
Falls Church 7
Guangzhou 7
Leawood 7
Quito 7
Verona 7
Ankara 6
Casalecchio Di Reno 6
Charlotte 6
Haiphong 6
Montréal 6
Rio de Janeiro 6
Rome 6
Zhengzhou 6
Amsterdam 5
Totale 6.605
Salva come PNG Salva come JPEG
Nome #
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study. 237
TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis 212
“Bridging the Gap” Everything that Could Have Been Avoided If We Had Applied Gender Medicine, Pharmacogenetics and Personalized Medicine in the Gender-Omics and Sex-Omics Era 202
Antiglaucoma drops influence the production of advanced glycation end-products (AGEs) in the conjunctival sac fluid of glaucoma patients 199
Matrix metalloproteinase 9 as a marker of disease activity in multiple sclerosis 178
Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients 178
Anomeric specificity and protein-substrate interactions support the 3D model for the hemagglutinin-neuraminidase from Sendai virus 176
Mutual communication of envelope glycoproteins of paramixoviruses 174
Vaginal lactoferrin modulates PGE2, MMP-9, MMP-2, and TIMP-1 amniotic fluid concentrations 169
Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis 163
Schematic overview of oligosaccharides, with survey on their major physiological effects and a focus on milk ones 163
Antiproliferative effects of novel synthetic nucleobase analogues on U937 Histiocytic lymphoma cell line 162
A proteomic approach to detect gelatinases levels and their inhibitors in patients with neurological diseases 160
Clinical and MRI activity are associated to elevated cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-9 in multiple sclerosis patients 158
Fast skeletal troponin i, but not the slow isoform, is increased in patients under statin therapy: A pilot study 155
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study 154
Serum Gelatinases Levels in Multiple Sclerosis Patients during 21 Months of Natalizumab Therapy 153
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 are elevated in in multiple sclerosis patients with disease activity 153
Effect of pH on MMP-9 release by LPS-stimulated neutrophils 151
ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES Identification of a TIMP-1-resistant active MMP-9 in serum of Multiple Sclerosis patients 151
Substrate binding to 6-phosphogluconate dehydrogenase 151
Matrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme forms 150
Peptides derived from the heptad repeat region near the C-terminal of Sendai virus F protein bind the hemagglutinin-neuraminidase ectodomain 150
Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding 150
Effect of antiglaucoma drops on advanced glycation end-products (AGEs) levels in conjunctival sac fluid 144
Conformational transitions during thermal inactivation of the neuraminidase from sendai virus 140
Low Molecular Weight Heparin as inhibitor of gelatinases: possile anti-inflammatory role 140
Analysis of MMP-9 in CSF and sera of patients with neurological diseases 140
Elevated CSF and serum levels and intrathecal synthesis of active MMP-2 in MS patients with no evidence of MRI disease activity 139
Biochemical study in adult population with stroke in Ferrara, Fabry disease 133
Thermal stability of the hemagglutinin-neuraminidase from Sendai virus evidences two folding domains 132
null 128
Limited preotolysis of cHN, the soluble hemagglutinin neuraminidase from sendai virus 126
Purification of transglutaminase enzyme from Leishmania infantum promastigotes 126
Hydroxyethyl Starch 130/0.4 Binds to Neutrophils Impairing Their Chemotaxis through a Mac-1 Dependent Interaction 126
Studies of Interaction between Sendai Virus Envelope Glycoproteins (HN ad F) by Syntetic peptides derived from the HR2 Region of the F Protein 123
INTRATHECAL PRODUCTION OF ACTIVE FORM OF MATRIX METALLOPROTEINASES-9 IN PATIENTS WITH MULTIPLE SCLEROSIS: PRELIMINARY RESULTS” 123
SERUM GELATINASES LEVELS IN MULTIPLE SCLEROSIS PATIENTS DURING 21 MONTHS OF NATALIZUMAB TREATMENT 121
Domain structure of the hemagglutinin-neuraminidase from sendai virus 119
Catalytic mechanism of 6-phosphogluconate dehydrogenase investigated by site-directed mutagenesis 118
Selective inhibition of Trypanosoma brucei 6-phosphogluconate dehydrogenase by high energy intermediate and transition state analogues 118
A Calcium- and GTP-Dependent Transglutaminase in Leishmania infantum 115
Inflammation and axonal damage biomarkers in Multiple Sclerosis: new perspective on their role 113
Influence of different strategies of volume replacement on the activity of matrix metalloproteinases: an in vitro and in vivo study 112
Heparin binds Matrix Metalloproteinase-9 (MMP-9): effect on the proteolytic activity 111
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis 111
null 110
Active myeloperoxidase: a promising biomarker to differentiate “acute” and “low-grade” peri-prosthetic joint infections from aseptic failures 108
Purification of transglutaminase enzyme from L. infantum promastigotes 107
Gelatinases: enzymatic activity as potential biomarker in multiple sclerosis 105
Extracellular pH modulates the release of Matrix Metalloproteinase-9 (MMP-9) by stimulated neutrophils and its activity. 105
null 104
Fluids administration modulate the matrix metalloproteinase-9 (MMP-9), myeloperoxidase (MPO) activities and inflammatory neutrophils response 104
Matrix metalloproteinase-2 (MMP-2) immune functions via surface proteolytic shedding of HLA-G1 molecules 104
Gelatinase: enzymatic activity as potential biomarker in multiple sclerosis 104
Possibile association between cerebrospinal fluid and serum levels of active matrix metalloproteinase-2 and MRI inactivity in multiple sclerosis patients 100
Enzymatic activation of NCX4016, a nitrate ester derivative of Aspirin 100
null 97
Thermodynamic characterization of 6-phosphogluconate dehydrogenase ternary complex 96
Unfording and limited proteolysis of the hemagglutinin-neuraminidase from sendai virus 94
MMP-9 isoforms in serum of Multiple Sclerosis patients 94
Influence of 6-aminonicotinamide (6AN) on Leishmania promastigotes evaluated by metabolomics: beyond the pentose phosphate pathway 92
Partial unfolding of the hemagglutinin-neuraminidase from sendai virus 91
Effects of anticoagulants on the activity of gelatinases 91
Matrix Metalloprotease-9 activity detected in body fluids is the result of two different enzyme forms 90
Synthetic peptides corresponding to the heptad repeat region of sendai virus fusion protein bind to the hemagglutinin-neuraminidase 89
Decreased arylesterase activity of paraoxonase-1 (PON-1) might be a common denominator of neuroinflammatory and neurodegenerative diseases 89
Differential pathogenicity and lethality of bubonic plague (1720–1945) by sex, age and place 88
Xenobiotics biodegradation: recombinant DCM dehalogenase from alcaligenes xylosoxydans 88
null 88
Fluids administration can modulate inflammatory neutrophils response and MMP-9 activity: an in vitro study 86
Gelatinase A (MMP-2) and B (MMP-9): their active forms as biomarkers in multiple sclerosis 85
Modulation of metalloproteinase-9 (MMP-9) by its specific tissue inhibitor (TIMP1) 79
Effects of anticoagulants on the activity of gelatinases 79
The influence of different replacement solutions on neutrophils response 79
inhibition of sendai virus fusion protein by interaction synthetic peptides derived F protein and hemagglutinin-neuraminidase 78
Vaginal Lactoferrin Administration Decreases Oxidative Stress in the Amniotic Fluid of Pregnant Women: An Open-Label Randomized Pilot Study 66
pH dependent structural changes of the hemagglutinin-neuraminidase from sendai virus 65
Effects of two different strategies of fluid administration on inflammatory mediators, plasma electrolytes and acid/base disorders in patients undergoing major abdominal surgery: a randomized double blind study. 64
Chemical and biological versatility of pyrazolo[3,4-d]pyrimidines: one scaffold, multiple modes of action 61
Sex-Related Differences of Matrix Metalloproteinases (MMPs): New Perspectives for These Biomarkers in Cardiovascular and Neurological Diseases 60
Lactoferrin administration prior to genetic amniocentesis dampens the intraamniotic inflammatory response 56
null 53
null 49
Influence of different strategies of volume replacement on the activity of metalloproteinases 9 42
Commentary on the Issue of Leishmania Infection: Focus on Some Pathogenetic, Clinical, and Epidemiological Aspects 31
BACE-1 and ADAM-10 as Potential Peripheral Biomarkers for Alzheimer’s Disease 2
Sex differences in biomarkers: Implications for age-related diseases 1
Totale 10.181
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.249
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1
Totale 48.250
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021573 0 0 0 0 0 100 54 93 24 121 139 42
2021/2022639 21 70 26 21 27 25 19 25 19 71 45 270
2022/2023791 77 66 20 95 134 106 47 69 84 11 52 30
2023/2024407 42 48 16 15 61 40 10 24 17 12 8 114
2024/20251.818 49 42 153 73 216 152 68 98 263 232 276 196
2025/20262.676 502 227 410 610 685 242 0 0 0 0 0 0
Totale 10.181